PVLA Stock: Earnings, Dividends & Analyst Estimates

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $60.49 - $161.38

10 Year PVLA Performance Metrics:

Total Return (with DRIP): -12.0% (-1.27% CAGR)

Total Return (no DRIP): -12.0% (-1.27% CAGR)

Share Price: -5.7% (-0.58% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $8,797

Total Return $ (with DRIP): -$1,203

PVLA Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

PVLA Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for PVLA

Based on past 10-year performance, here are PVLA growth metrics:

Share price CAGR of -0.58%
Dividend CAGR of +0%

Using PVLA CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	PVLA (DRIP)	PVLA - No DRIP
Current Price	$137.93	$137.93
Start Shares	72.50	72.50
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	72.50	72.50
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$130.09	$137.93
Total Dividends	$0	$0
Final Value	$9,432	$10,000

Estimated Future Value + Dividends - PVLA

NOTE: Above numbers are our estimate based on PVLA's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Palvella Therapeutics, Inc. (PVLA) had its IPO on , and is traded on NASDAQ stock exchange.

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for serious, rare skin diseases and vascular malformations with no FDA-approved treatment options. The company centers its work on dermatology-focused rare disease programs, using its proprietary QTORIN platform to create topical therapies designed for localized delivery in difficult-to-treat conditions. Its current pipeline includes product candidates being studied for microcystic lymphatic malformations, cutaneous venous malformations, and clinically significant angiokeratomas, reflecting a focus on genetically driven and orphan skin disorders. Palvella Therapeutics serves the rare disease and specialty dermatology markets, where targeted medicines can address conditions that are often chronic, burdensome, and underserved by existing therapies. Palvella Therapeutics, Inc. is headquartered in Wayne, Pennsylvania.

PVLA website: https://palvellatx.com